Aleafia Health (TSX: AH) this morning became the latest cannabis operator to announce an at-the-market financing. The company will look to raise $30 million via the ATM program.
Lead by Cantor Fitzgerald, the financing will see the company sell its shares directly on the markets rather than through brokers. The company intends to conduct the financing program just on the Toronto Stock Exchange, with the transaction not to include its US-based listing.
The financing is set to run until June 20, 2023, or until the financing is completed in full, whichever occurs first. Proceeds from the financing are to be used for “growth opportunities” and working capital.
Aleafia Health last traded at $0.44 on the TSX.
Information for this briefing was found via Sedar and Aleafia Health. The author has no affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
Why Public Cannabis CFOs Need to Breakdown and Segment Their Accounts Receivables
Limited Disclosures Risk Signaling Poor Financial Health to Analysts and Investors The ‘accounts receivable to...